Canadian Varicocelectomy Initiative (CVI): Effects on Male Fertility and Testicular Function of Varicocelectomy
CVI
A Prospective, Multi-Centre, Randomized Controlled Study Comparing Varicocelectomy to Observation in Infertile Men With Clinical Varicoceles
1 other identifier
interventional
300
1 country
4
Brief Summary
A varicocele is the presence of dilated testicular veins in the scrotum. Although it is generally agreed that a varicocele is the most common identifiable pathology in infertile men (detected in up to 40% of men in some series of men with infertility), the influence of a varicocele on male fertility potential and role of varicocelectomy in restoring of fertility remain the subject of ongoing controversy. The present controversy on the effect of varicocelectomy on male fertility potential has led many clinicians to dismiss the diagnosis of a varicocele altogether and instead, offer alternative treatments to the couple. Many of these alternative therapies are expensive and risky for the patients and their children. Several recent reviews have critically examined the results of randomized, controlled trials of varicocelectomy on fertility potential. The effect of varicocelectomy on spontaneous pregnancy rates remains controversial. The investigators hypothesize that a varicocelectomy will result in a significant improvement in fertility and testicular function in infertile men with a clinical varicocele.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2009
CompletedFirst Posted
Study publicly available on registry
August 19, 2009
CompletedMay 28, 2012
August 1, 2011
August 17, 2009
May 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy rates in infertile couples 6 months after surgery or observation alone
7 months after randomization
Secondary Outcomes (1)
Mean improvements in sperm parameters, serum testosterone levels 6 months after surgery or observation alone; complication rate after varicocelectomy; mean time (days) off work after varicocelectomy.
7 months after randomization
Study Arms (2)
Observation arm
NO INTERVENTIONPatient will not to undergo any form of Assisted Reproductive Technologies for a period of 6 months
Surgery Arm
OTHERPatients will have varicocelectomy within 1 month of assessment and will not undergo any form of Assisted Reproductive Technologies for a period of 6 months after surgery
Interventions
Varicocelectomy
Eligibility Criteria
You may qualify if:
- Minimum of one year of infertility
- Clinically detectable grade 2 or grade 3 varicocele
- A minimum of 2 abnormal semen analyses (defined as \< 20 million sperm/ml, and/or \< 30% progressive motility and/or normal sperm morphology \< 14% by Kruger Strict Morphology (WHO) within 6 months of entry into the study)
- Female partner \< 38 years of age
You may not qualify if:
- Other medically correctable cause of infertility (e.g., prolactinoma, infection, exposure to marijuana)
- Severe oligospermia on 2 sperm analyses (defined as \< 5 million sperm/ml)
- Severe asthenospermia on 2 sperm analyses (\< 5% progressive motility)
- Prior varicocele repair
- Solitary testicle
- Significant female-factor infertility (tubal factor or anovulation only)
- Inability or unwillingness to comply with study protocol (including failure to submit 2 post-intervention semen samples)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mount Sinai Hospital, Canadalead
- McGill Universitycollaborator
- Dalhousie Universitycollaborator
- McMaster Universitycollaborator
Study Sites (4)
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, B3H 2A7, Canada
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5, Canada
McGill University Health Centre; Royal Victoria Hospital
Montreal, Quebec, H3A 1A1, Canada
McGill University; St. Mary Hospital Centre
Montreal, Quebec, H3T 1M5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Keith A Jarvi, MD
MOUNT SINAI HOSPITAL
- STUDY DIRECTOR
Armand S Zini, MD
McGill University
- PRINCIPAL INVESTIGATOR
Kirk C Lo, MD
MOUNT SINAI HOSPITAL
- PRINCIPAL INVESTIGATOR
Ethan D Grober, MD
MOUNT SINAI HOSPITAL
- PRINCIPAL INVESTIGATOR
Peter T Chan, MD
McGill University
- PRINCIPAL INVESTIGATOR
John E Grantmyre, MD
Dalhousie University
- PRINCIPAL INVESTIGATOR
Edward G Hughes, MD
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 17, 2009
First Posted
August 19, 2009
Last Updated
May 28, 2012
Record last verified: 2011-08